Blood Sample Protein Measurement Analysis

The Washington DC VA Medical Center is seeking vendor capabilities to perform high-plex proteomic analysis on approximately 120 coded frozen plasma samples from 24 Veterans with advanced metastatic prostate cancer, aiming to identify circulating protein signatures linked to treatment response and disease progression. The work will be conducted under a Firm Fixed Price contract at the vendor’s CLIA-certified facility using the SomaScan® Assay Platform, version 4.1 or later, with all samples shipped and maintained at -80°C throughout transit and processing. Deliverables include proteomic data in standard ADAT format, a PDF assay quality statement, and the return of any unused biological samples to the VA at 50 Irving St., Washington, DC 20422, all of which are U.S. Government property. The contract includes a base year with a one-year option and requires strict adherence to VA data handling protocols under the Privacy Act, FOIA, NARA, and NIST guidelines, including prohibitions against co-mingling VA data with non-VA information and mandatory destruction or return of data upon contract termination with written certification. Vendors must provide their Unique Entity Identifier, disclose their small business or socioeconomic status, and demonstrate experience with CLIA-certified proteomic workflows and cold chain logistics; however, no evaluation weights, scoring criteria, or award methodology are specified as this is a sources-sought notice for market research. All submissions must be sent via email to Veronica Dillard by 3:00 PM EDT on May 15, 2026, and include business information, a capability statement, past performance details, and quality assurance documentation in standard electronic formats such as PDF or DOCX, with no formal page limits imposed.